The Middle East and Africa Animal Healthcare Market is anticipated to grow at a CAGR of 5.4% with USD 5,538.1 Mn share in 2026 and is expected to reach USD 7,895.7 Mn in 2033. Rising livestock population & food security needs (livestock plays a critical economic role, especially in Africa, for instance, according to the data published by the Food and Agricultural Organization, approximately 30% of agricultural GDP in Sub-Saharan Africa is generated from livestock farming, with significant contributions from cattle, sheep, goats, and poultry), increasing demand for animal-based protein, and rising pet ownership are the significant factors responsible for the Middle East and Africa animal healthcare market growth over the forecast period.
FA0;
Source: FAO
Source: WOAH
Source: FAO
Source: FAO
Vaccines are projected to account for the largest share of Middle East and Africa animal healthcare in 2026, representing approximately 52.0% of the total volume. Government across Middle East and Africa actively run national immunization campaigns. GCC countries have strict vaccination for imported livestock and African countries are donor-supported vaccination drives (FAO, WOAH). Hence, due to government vaccination programs and strict vaccination laws there is bulk procurement of vaccines and regular repeated demand cycles. For instance, the Food and Agriculture Organization (FAO) supported a nationwide livestock vaccination campaign targeting highly contagious animal diseases such as Peste des Petits Ruminants (PPR), sheep and goat pox, contagious bovine pleuro‑pneumonia (CBPP) and African horse sickness, running from October 2025 through January 2026 to protect approximately 9.4 million livestock in Sudan. This initiative was driven by FAO and national government veterinary services to immunize herds and reduce disease spread in key animal populations. This shows that government immunization programs backed by the FAO produce cycles of bulk buying and repeated need for vaccinations in Africa, which keeps demand high in the vet healthcare sector.
Based on animal type, livestock dominate the market, accounting for a significant 78.0% share in 2026, attributing to region’s economy, food systems, and public health priorities are heavily tied to livestock. Large livestock population base has driven the segment growth significantly in the market. According to the Food and Agriculture Organization (FAO) estimates Eastern Africa’s cattle herd alone exceeds 150 million animals and represents nearly 40% of Africa’s total cattle population. Furthermore, according to the data published by the Springer Nature, in November 2025, chickens alone made up roughly 59.4% of the primary livestock population in Africa's livestock production systems, followed by goats (13.5%), sheep (11.7%), and cattle (10.5%). This illustrates the vast and varied livestock population base that continues to support the region's high demand for animal health products. Hence, large number of animals increases the demand for routine treatment, disease prevention and veterinary services. This directly makes livestock the largest revenue-generating segment. In addition, Livestock export markets require disease-free certification and vaccinated animals which is important for Middle East livestock imports and African export economies and encourages systematic healthcare adoption.

To learn more about this report, Download Free Sample
Veterinary Clinics account for the largest share of 38.0% in 2026 due to increasing awareness of animal health & welfare, growth in companion animal (Pet) ownership and rising demand for professional veterinary services. By 2024–2025, around 66% of U.S. households—approximately 86.9 to 95 million—own a pet, reflecting a strong increase over the past three decades. Dogs are the most common, present in about 65.1 million homes, followed by cats in roughly 46.5 million households. Rising demand for professional veterinary services has significantly driven the growth of the segment in the market. Increasing need for diagnosis, treatment, surgeries, and emergency care has increased frequency of veterinary clinics visits. Veterinary clinics provide comprehensive services, making them the primary point of care. Increasing awareness of animal health & welfare leads to regular check-ups and preventive care (vaccination, deworming). Clinics are the main delivery channel for these services. Rapid increase in pet adoption in UAE, South Africa and Saudi Arabia has increased demand for the routine health care and specialized treatments. Veterinary clinics become the primary service providers for pets. Rapid urban growth in cities like Riyadh, Dubai, and Nairobi leads to higher disposable income and willingness to spend on animal healthcare which drives more visits to clinics and hospitals. For instance, according to the government of Dubai’s official statistics authority estimates the emirate’s population at 4.248 million at end-2024, up from 3.718 million in 2022, which is about 14.3% growth in two years. The same bulletin shows 5.938 million active individuals during peak hours, reflecting a much larger daytime service base. In parallel, the official Dubai Pulse dataset for animal hospitals and clinics showed 400 records, updated on 26 January 2026, while the IMF’s April 2026 outlook puts UAE GDP per capita at about US$54,210 in 2026. Together, these indicators support stronger affordability and higher use of organized veterinary services.
Rapid population growth and increasing urbanization has increased the demand for the higher protein consumption. Middle East and Africa countries are increasing meat and dairy production to reduce import dependency. Increasing demand for animal-based food has expanded livestock farming. Expansion of livestock farming has eventually increased demand for anti-infectives, vaccines, and feed additives.
According to FAO, the demand for animal products in emerging nations is predicted to more than quadruple by 2030 as a result of population increase, rising affluence, and shifting diets that prioritize consuming more protein. In order to safeguard herd health and guarantee food safety, this ongoing livestock expansion highlights the increased need for vaccinations, anti-infectives, and other veterinary health inputs.
According to the OECD Agricultural Outlook, global meat production was approximately 365 million tonnes in 2024, with Africa contributing about 6 % of this output, underscoring increasing regional livestock production. FAO’s FAOSTAT database, which tracks livestock populations and production volumes up to the most recent year, provides the statistical basis for projecting continued demand growth in 2026 and beyond.
Rising cases of animal & zoonotic diseases is a major factor influencing the growth of the Middle East and Africa animal healthcare market size over the forecast period. Frequent outbreaks such as avian influenza, African swine fever and foot and mouth disease have increased demand for diagnostics, vaccines and therapeutics which has driven the growth of the market.
For instance, in 2026, according to the data published by the official WOAH/WAHIS, numerous outbreaks of foot-and-mouth disease (including SAT-1) were confirmed in African nations like Botswana, Lesotho, Zambia, Eswatini, and Zimbabwe. Additionally, cases of African swine fever were reported in Kenya and Cabo Verde, and other diseases like anthrax and African horse sickness continue to affect livestock health. All of these factors have increased demand for diagnostics, vaccines, and treatments in the Middle East and Africa animal healthcare market. These ongoing disease pressures are consistent with WOAH's worldwide reporting that priority illnesses including FMD, avian influenza, and African swine fever continue to pose serious risks and call for more veterinary intervention. Moreover, as of 26 February 2026, there were 64 total reported outbreaks of SAT2 FMD, affecting a susceptible livestock population of approximately 51,178 cattle and swine. While this is predominantly SAT2, it illustrates the high burden of FMD variants in southern Africa in 2026.
Increasing government initiatives and international support programs has created significant opportunity for the growth of the Middle East and Africa animal healthcare market over the forecast period. In 2026, governments in the Middle East and Africa have strengthened official animal healthcare programs in collaboration with international partners, expanding opportunities for veterinary services, vaccines, and diagnostics. For instance, the World Organisation for Animal Health (WOAH) and regional authorities organized a webinar on 17 March 2026 on advancing the One Health approach for control of zoonotic tuberculosis in Africa, bringing together national Programme managers, veterinary and public health experts to enhance cross‑sectoral disease surveillance and control capacities across African countries. This represents a government‑supported initiative integrating animal health and public health systems to better prevent and manage zoonotic diseases, directly increasing demand for veterinary healthcare solutions. Furthermore, in 2026, the Food and Agriculture Organization's 2026 animal health event calendar features a number of government-aligned webinars, such as "Current global situation and emerging risks for foot-and-mouth disease" on April 1, 2026, and the introduction of a new animal mpox case detection guide on February 18, 2026, with the goal of enhancing national disease prevention strategies, surveillance, and laboratory capacity in areas like the Middle East and Africa. These official programs promote investment in diagnostics, vaccinations, and treatments while bolstering preventative veterinary care.
|
Current Event |
Description and its Impact |
|
Ministerial Ban on Import of Live Birds in Oman |
|
|
Reformation of South African and UAE Veterinary Regulations
|
|
|
UN High‑Level Emphasis on Animal Health in 2026 Pandemic Prevention Agenda |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Middle East account 55.0% market share in 2026, supported by rapidly expanding livestock healthcare services and investment in preventive veterinary care (including livestock disease control, vaccinations, and pharmaceuticals). The region’s emphasis on food security, rising demand for animal‑derived proteins, and expanding veterinary infrastructure have supported its market dominance within the Middle East & Africa segment. The emphasis on Foot and Mouth Disease prevention and herd protection in the Middle East is in line with rising veterinary expenditures and the requirement for widespread immunization to reduce the dangers of transboundary diseases, which increases demand for preventive care solutions. For instance, in January 2026, according to Food and Agriculture Organization's immunization report, more than 3.9 million animals, including cattle, goats, sheep, and donkeys, received vaccinations. This widespread vaccination of animals is a reflection of rising regional investments in preventative care, which is consistent with a rise in the use of efficient livestock health management strategies, particularly in Middle Eastern countries with high disease risks. The Middle East's expanding animal healthcare business is supported by these vaccination campaigns.
Similarly, the Foot and Mouth Disease vaccination strategy can be referenced under "Disease Control in the Middle East" to show how regional efforts are focusing on preventing the spread of transboundary diseases and improving livestock protection. For instance, in March 2026, FAO’s Rapid Risk Assessment for Foot‑and‑Mouth Disease (FMD) highlighted the very likely risk of FMDSAT1 spread across several Middle Eastern and neighboring countries as of Feb 2026, which underscores the necessity for mass vaccination coverage and herd protection strategies in the region to mitigate transboundary risk.
The Africa region is poised to be as the fastest-growing region through 2026-2033, owing to growing livestock health investments, especially in preventive care (vaccines, parasiticides, and nutritional interventions) to support rising animal protein production and food security goals. Market expansion is underpinned by: Increasing awareness of livestock disease impacts on productivity and income, Greater adoption of modern veterinary practices & pharmaceuticals. Rising government and NGO initiatives targeting livestock disease control and animal welfare in Africa has significantly driven the growth of the market over the forecast period. In Africa, the growing demand for vaccination, parasiticides, and veterinary care as part of a preventive health strategy to safeguard livestock populations against diseases that affect food security. For instance, in January 2026, according to the data published by the Food and Agriculture Organization updated reports it have been estimated that nearly 4 million animals (including 1.3 million cattle, 1.8 million goats, and 777,000 sheep) were vaccinated in Africa during 2025. This large‑scale vaccination effort underscores the expanding preventive health measures being adopted across the region, supporting the growing animal healthcare market. Such initiatives directly contribute to the region’s increasing demand for veterinary services, with vaccines and treatment strategies becoming integral components of the broader livestock health investment framework.
In order to meet the growing domestic demand for meat and dairy products, Saudi Arabia's livestock industry keeps growing. The need for vaccines, anti-infectives, parasiticides, and veterinary medications is directly rising as livestock numbers increase and farmers invest more in animal health services to maintain production and guarantee food security. For instance, in order to achieve food security, self-sufficiency, and agricultural modernization, Saudi Arabia is making significant investments in animal health programs as part of its Vision 2030. The Ministry of Environment, Water, and Agriculture of Saudi Arabia aggressively supports improved animal husbandry, widespread vaccination campaigns (such as against avian influenza and FMD), and disease surveillance. By lowering the risk of disease and enhancing herd health, these programs support steady demand for veterinarian care and animal health products.
The South Africa is the dominant country in the Africa animal healthcare market, driven by rising disease awareness among livestock producers, increasing preventive care adoption, and strategic responses to infectious disease pressure that emphasize vaccination and improved herd health management. Increasing launch of domestically produced foot and mouth disease vaccine in South Africa is significantly driving the growth of the market. For instance, On February 6, 2026, South Africa formally introduced its first locally manufactured foot-and-mouth disease (FMD) vaccine in more than 20 years. This project, which was created by the Agricultural Research Council (ARC) at its Onderstepoort Veterinary Research facility, is an essential step toward attaining vaccine sovereignty and containing the worst FMD outbreak in the nation. This program, which aims to vaccinate up to 80% of about 12 million cattle, including 7.2 million on commercial farms, is essential to lowering the spread of disease and productivity loss.
Source: africavet.com
Some of the major key players in Zoetis Inc., Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva, Bayer AG, Evonik Industries AG, and Archer Daniels Midland Company.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5,538.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.4% | 2033 Value Projection: | USD 7,895.7 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Zoetis Inc., Elanco, Merck & Co., Inc., Boehringer Ingelheim GmbH, Ceva, Bayer AG, Evonik Industries AG, and Archer Daniels Midland Company. |
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients